GR

Geetanjali Rajendra Nangare

Active Director Designated Partner DIN 08730659
DIN 08730659 First appointment Mar 2020 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Geetanjali Rajendra Nangare

Data last updated:

Geetanjali Rajendra Nangare is a Designated Partner at Nsbs Pharma Llp (since 2020). The company operates in Business Services.

DIN 08730659
Primary Designation Designated Partner
Industry Business Services
First Appointment 19 Mar 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nsbs Pharma Llp AAR-6961
Designated Partner19 Mar 20202020Active

Board colleagues of Geetanjali Rajendra Nangare

NameDINCompanyDesignation
Rishikesh Rajendra Nangare08676880Nsbs Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Nsbs Pharma Llp
Premium access

Shareholding and investment profile for Geetanjali Rajendra Nangare

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Geetanjali Rajendra Nangare

Geetanjali Rajendra Nangare currently holds 1 directorship: Nsbs Pharma Llp (Designated Partner, since 19 Mar 2020).

Geetanjali Rajendra Nangare was first appointed on 19 Mar 2020 as Designated Partner at Nsbs Pharma Llp.

The current boards of Geetanjali Rajendra Nangare's companies include Rishikesh Rajendra Nangare (Nsbs Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available